Cirius Therapeutics Competitors and Similar CompaniesClear all
Cirius Therapeutics's competitors and similar companies include Ipsen and Chiesi Group.
 Cirius Therapeutics Cirius Therapeutics, a clinical-stage pharmaceutical company which is developing a next-generation insulin sensitizer for the treatment of nonalcoholic steatohepatitis. |  Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. | ||
Founding Date | Founding Date 2016 | Founding Date 1929 | Founding Date 1935 |
Type | Type Private | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Kalamazoo, US HQ San Diego, US | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more |
Employees | Employees N/A | Employees 5,358 | Employees 5,8541% increase |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) €2.4b (Y, 2021) |
For sources of this data, please see the company profile
View Company Profiles
Chiesi Group
HQ
Parma, IT
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View company